טוען...
Assessing Pharmacokinetic Marker Correlates of Outcome, with Application to Antibody Prevention Efficacy Trials
The Antibody Mediated Prevention (AMP) efficacy trials are the first studies to evaluate whether passive administration of a broadly neutralizing monoclonal antibody (mAb) can prevent HIV acquisition. The trials randomize 4600 HIV-negative volunteers to receive 10 infusions of the mAb VRC01 or place...
שמור ב:
| הוצא לאור ב: | Stat Med |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736712/ https://ncbi.nlm.nih.gov/pubmed/31313349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8310 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|